PR Newswire Clinical TrialsOriginal article
JaxBio Announces npj Precision Oncology Study Showing $60 cfDNA Methylation Chip Detected Lung Cancer Signals in Blood Without Sequencing
Data ReadoutpositivecfDNA Methylation Chip ($60)Positive
AI Analysis
Summary
JaxBio Technologies announced peer-reviewed study results published in npj Precision Oncology demonstrating that their $60 cfDNA methylation chip can detect lung cancer signals in blood without requiring sequencing. The method uses hybrid capture on-chip and enzyme-based fluorescent labeling to profile cancer-associated cfDNA methylation patterns.
Outcome Details
peer-reviewed study published in npj Precision Oncology showing cfDNA methylation chip detected lung cancer signals in blood without sequencing using hybrid capture on-chip and enzyme-based fluorescent labeling method
Importance:5/10
Sentiment:
0.60
liquid biopsycfDNA methylationlung cancerdiagnosticspeer-reviewed publicationblood test
Read the original article
Published by PR Newswire Clinical Trials on July 2, 2026 12:55 PM